Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis

IFNβ is a common therapeutic option to treat multiple sclerosis. It is unique among the family of type I IFNs in that it binds to the interferon receptors with high affinity, conferring exceptional biological properties. We have previously reported the generation of an interferon superagonist (dubbe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Harari, Daniel, Kuhn, Nadine, Abramovich, Renne, Sasson, Keren, Zozulya, Alla L., Smith, Paul, Schlapschy, Martin, Aharoni, Rina, Köster, Mario, Eilam, Raya, Skerra, Arne, Schreiber, Gideon
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Biochemistry and Molecular Biology 2014
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4200257/
https://ncbi.nlm.nih.gov/pubmed/25193661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M114.602474
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados